LA JOLLA PHARMACEUTICAL CO's ticker is LJPC and the CUSIP is 503459604. A total of 42 filers reported holding LA JOLLA PHARMACEUTICAL CO in Q2 2022. The put-call ratio across all filers is - and the average weighting 2.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $17,000 | -39.3% | 5,407 | -18.0% | 0.00% | – |
| Q1 2022 | $28,000 | -57.6% | 6,592 | -53.4% | 0.00% | – |
| Q4 2021 | $66,000 | -16.5% | 14,156 | -28.4% | 0.00% | – |
| Q3 2021 | $79,000 | -46.3% | 19,782 | -42.3% | 0.00% | – |
| Q2 2021 | $147,000 | -33.8% | 34,306 | -34.5% | 0.00% | – |
| Q1 2021 | $222,000 | +117.6% | 52,400 | +98.5% | 0.00% | – |
| Q4 2020 | $102,000 | +121.7% | 26,396 | +127.3% | 0.00% | – |
| Q3 2020 | $46,000 | -33.3% | 11,612 | -28.0% | 0.00% | – |
| Q2 2020 | $69,000 | 0.0% | 16,124 | -2.0% | 0.00% | – |
| Q1 2020 | $69,000 | -17.9% | 16,446 | -21.9% | 0.00% | – |
| Q4 2019 | $84,000 | -34.9% | 21,050 | +44.1% | 0.00% | – |
| Q3 2019 | $129,000 | -13.4% | 14,612 | -8.9% | 0.00% | – |
| Q2 2019 | $149,000 | +49.0% | 16,037 | +2.9% | 0.00% | – |
| Q1 2019 | $100,000 | -81.0% | 15,587 | -72.1% | 0.00% | – |
| Q4 2018 | $527,000 | -48.2% | 55,946 | +10.6% | 0.00% | – |
| Q3 2018 | $1,018,000 | -57.0% | 50,593 | -37.7% | 0.00% | – |
| Q2 2018 | $2,368,000 | +66.2% | 81,159 | +69.5% | 0.00% | – |
| Q1 2018 | $1,425,000 | +46.5% | 47,879 | +58.3% | 0.00% | – |
| Q4 2017 | $973,000 | -43.4% | 30,248 | -38.8% | 0.00% | – |
| Q3 2017 | $1,719,000 | +85850.0% | 49,395 | +48805.9% | 0.00% | – |
| Q2 2017 | $2,000 | -97.3% | 101 | -95.9% | 0.00% | – |
| Q1 2017 | $74,000 | -86.0% | 2,481 | -91.8% | 0.00% | – |
| Q4 2016 | $528,000 | -23.1% | 30,101 | +4.3% | 0.00% | – |
| Q3 2016 | $687,000 | +5184.6% | 28,862 | +3287.6% | 0.00% | – |
| Q2 2016 | $13,000 | +1200.0% | 852 | +3308.0% | 0.00% | – |
| Q1 2016 | $1,000 | -92.9% | 25 | -95.1% | 0.00% | – |
| Q4 2015 | $14,000 | +1300.0% | 510 | +1143.9% | 0.00% | – |
| Q3 2015 | $1,000 | -87.5% | 41 | -87.1% | 0.00% | – |
| Q2 2015 | $8,000 | – | 317 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TANG CAPITAL MANAGEMENT LLC | 2,914,970 | $81,007,000 | 29.87% |
| RTW INVESTMENTS, LP | 1,080,331 | $30,022,000 | 9.33% |
| Avoro Capital Advisors LLC | 804,299 | $22,351,000 | 5.81% |
| ACUTA CAPITAL PARTNERS, LLC | 122,222 | $3,397,000 | 1.97% |
| Broadfin Capital, LLC | 1,095,373 | $30,440,000 | 1.69% |
| Belmont Global Advisors, Inc. | 35,000 | $973,000 | 1.65% |
| P.A.W. CAPITAL CORP | 48,000 | $1,334,000 | 1.53% |
| Perceptive Advisors | 1,309,030 | $36,378,000 | 1.45% |
| Iguana Healthcare Management, LLC | 125,000 | $3,474,000 | 1.37% |
| EAM Investors, LLC | 97,350 | $2,705,000 | 0.43% |